advisory committee

brain alzheimers dementia neuroscience gears thought think
Biotech

Lilly's donanemab sails through FDA meeting with 2 yes votes

Lilly’s Alzheimer’s drug sailed through an FDA meeting, with panelists praising the therapy as innovative—while cautioning about a lack of data on subgroups.
Annalee Armstrong Jun 10, 2024 5:11pm
setback chess beat defeat rook break

Lykos' MDMA treatment rejected by FDA committee

Jun 5, 2024 10:20am
blood test vials

Guardant preps for FDA review of colorectal cancer blood test

May 13, 2024 1:48pm
FDA approved stamp regulations yes go

FDA wants to hear from you on future of adcomm meetings

Apr 29, 2024 12:51pm
Richard Pazdur

FDA's Richard Pazdur explains confirmatory trial rejection, more

Apr 8, 2024 6:00am
FDA

FDA panel supports Abbott's TriClip in tricuspid regurgitation

Feb 14, 2024 11:05am